Company intelligence / Profile preview

ARx

Glen Rock, Pennsylvania, United States

Ownership: Private
Development stage: Other

Overview

ARx is a leading US-based CDMO (contract development and manufacturing organization) focused on advanced drug delivery systems including oral thin films and transdermal patches. It is a subsidiary of Adhesives Research, founded in 2005, and is recognized for its partnership-oriented approach, FDA compliance, and successful commercial products, especially in pediatric and geriatric segments. ARx leverages advanced polymer science and proprietary platforms such as MicroDEP to bring next-generation absorption and rapid-onset therapeutic dosing.

Therapeutic areas: Infectious DiseasesGastroenterology
Modalities: Oral thin filmTransdermal patchSmall moleculeBiologic
Industry: Contract Manufacturing Organization

Partnerships

Novartis Consumer HealthGas-Xother generic and branded drug companies

Beyond the preview

Go deeper on ARx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ARx.

Explore the full profile